Minimal Residual Disease (MRD) Market: Global Growth Outlook
The global Minimal Residual Disease (MRD) Market is projected to reach USD 2.55 billion by 2029, rising from USD 1.43 billion in 2024, at a CAGR of 12.2% during the forecast period. This growth is driven by the rising incidence of cancer and hematological malignancies, expanding government awareness initiatives, and an increasing number of collaborations and research partnerships across the diagnostics...